midazolam has been researched along with Child Mental Disorders in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Tristan, MA | 1 |
| Martin-Marchand, L | 1 |
| Roué, JM | 1 |
| Anand, KJS | 1 |
| Pierrat, V | 1 |
| Tourneux, P | 1 |
| Kuhn, P | 1 |
| Milesi, C | 1 |
| Benhammou, V | 1 |
| Ancel, PY | 1 |
| Carbajal, R | 1 |
| Durrmeyer, X | 1 |
1 other study available for midazolam and Child Mental Disorders
| Article | Year |
|---|---|
Association of Continuous Opioids and/or Midazolam During Early Mechanical Ventilation with Survival and Sensorimotor Outcomes at Age 2 Years in Premature Infants: Results from the French Prospective National EPIPAGE 2 Cohort.
Topics: Analgesics, Opioid; Cohort Studies; Female; France; Humans; Hypnotics and Sedatives; Infant; Infant, | 2021 |